Drug profile

The FDA adverse-event record for Vitamin K1

79 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Vitamin K1. See the species affected, top reactions, and outcomes below.

79
adverse-event reports
60.8%
death-coded share
Dog
most-reported species
41
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
79
Total Reports
48
Deaths Reported
60.8%
Death Rate

Active Ingredients

Vitamin K1

Administration Routes

UnknownOralSubcutaneous

Species Affected

Dog 69
Cat 10

Most Affected Breeds

Retriever - Labrador 20
Domestic Shorthair 8
Terrier - Bull - American Pit 3
Crossbred Canine/dog 3
Boxer (German Boxer) 3
Maltese 2
Griffon - Brussels 2
Shepherd (unspecified) 2
Mixed (Dog) 2
Domestic Longhair 2

Most Reported Reactions

Vomiting 41
Lethargy (see also Central nervous system depression in 'Neurological') 37
Other abnormal test result NOS 34
Death by euthanasia 30
Elevated total bilirubin 29
Anaemia NOS 28
Thrombocytopenia 28
Elevated alanine aminotransferase (ALT) 28
Anorexia 23
Elevated serum alkaline phosphatase (SAP) 23
Leucocytosis NOS 21
Elevated liver enzymes 21

Outcome Breakdown

Euthanized
30 (38.0%)
Ongoing
26 (32.9%)
Died
18 (22.8%)
Recovered/Normal
5 (6.3%)

Vitamin K1 Adverse Event Insights

79 reports name Vitamin K1; 48 recorded a death outcome (60.8% of reported events, not a population-level mortality rate). Active ingredient: Vitamin K1. Administration routes: Unknown, Oral, Subcutaneous.

By species: Dog (69 reports), Cat (10 reports). By breed: Retriever - Labrador (20), Domestic Shorthair (8), Terrier - Bull - American Pit (3).

Leading clinical signs: Vomiting (41), Lethargy (see also Central nervous system depression in 'Neurological') (37), Other abnormal test result NOS (34), Death by euthanasia (30). Outcome, 79 coded reports: Euthanized leads at 38.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.